BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 32799221)

  • 1. [Regulation of Gene Expression of Cancer/Testis Antigens in Colorectal Cancer Patients].
    Kutilin DS
    Mol Biol (Mosk); 2020; 54(4):580-595. PubMed ID: 32799221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MTUS1 and its targeting miRNAs in colorectal carcinoma: significant associations.
    Ozcan O; Kara M; Yumrutas O; Bozgeyik E; Bozgeyik I; Celik OI
    Tumour Biol; 2016 May; 37(5):6637-45. PubMed ID: 26643896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific Features of Transcription Activity of Cancer-Testis Antigens in Patients with Metastatic and Non-Metastatic Breast Cancer.
    Vodolazhsky DI; Kutilin DS; Mogushkova KA; Kit OI
    Bull Exp Biol Med; 2018 Jul; 165(3):382-385. PubMed ID: 30006881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic and epigenetic bases of prostate tumor cell radioresistance.
    Kutilin D
    Klin Onkol; 2021; 34(3):220-234. PubMed ID: 34362257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic and epigenetic bases of prostate tumor cell radioresistance.
    Kutilin Denis
    Ceska Gynekol; 2021; 86(3):220-234. PubMed ID: 34192880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression network regulated by DNA methylation and microRNA during microcystin-leucine arginine induced malignant transformation in human hepatocyte L02 cells.
    Chen HQ; Zhao J; Li Y; He LX; Huang YJ; Shu WQ; Cao J; Liu WB; Liu JY
    Toxicol Lett; 2018 Jun; 289():42-53. PubMed ID: 29518473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating miRNA Expression Profiles and Machine Learning Models in Association with Response to Irinotecan-Based Treatment in Metastatic Colorectal Cancer.
    Pliakou E; Lampropoulou DI; Dovrolis N; Chrysikos D; Filippou D; Papadimitriou C; Vezakis A; Aravantinos G; Gazouli M
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic regulation of microRNA expression in colorectal cancer.
    Bandres E; Agirre X; Bitarte N; Ramirez N; Zarate R; Roman-Gomez J; Prosper F; Garcia-Foncillas J
    Int J Cancer; 2009 Dec; 125(11):2737-43. PubMed ID: 19521961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic Alternations of MicroRNAs and DNA Methylation Contribute to Liver Metastasis of Colorectal Cancer.
    Liu J; Li H; Sun L; Shen S; Zhou Q; Yuan Y; Xing C
    Dig Dis Sci; 2019 Jun; 64(6):1523-1534. PubMed ID: 30604369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA profiling reveals dysregulated microRNAs and their target gene regulatory networks in cemento-ossifying fibroma.
    Pereira TDSF; Brito JAR; GuimarĂ£es ALS; Gomes CC; de Lacerda JCT; de Castro WH; Coimbra RS; Diniz MG; Gomez RS
    J Oral Pathol Med; 2018 Jan; 47(1):78-85. PubMed ID: 29032608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA Expression Levels and Histopathological Features of Colorectal Cancer.
    Emami SS; Akbari A; Zare AA; Agah S; Masoodi M; Talebi A; Minaeian S; Fattahi A; Moghadamnia F
    J Gastrointest Cancer; 2019 Jun; 50(2):276-284. PubMed ID: 29404790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ginsenoside 20(S)-Rg3 Inhibits the Warburg Effect Via Modulating DNMT3A/ MiR-532-3p/HK2 Pathway in Ovarian Cancer Cells.
    Zhou Y; Zheng X; Lu J; Chen W; Li X; Zhao L
    Cell Physiol Biochem; 2018; 45(6):2548-2559. PubMed ID: 29558748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computational Analysis of miRNA and their Gene Targets Significantly Involved in Colorectal Cancer Progression.
    Kandhavelu J; Subramanian K; Khan A; Omar A; Ruff P; Penny C
    Microrna; 2019; 8(1):68-75. PubMed ID: 30073936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SOX9, miR-495, miR-590-3p, and miR-320d were identified as chemoradiotherapy-sensitive genes and miRNAs in colorectal cancer patients based on a microarray dataset.
    Du B; Wang T; Yang X; Wang J; Shi X; Wang X; Wu D; Feng L; Chen L; Zhang W
    Neoplasma; 2019 Jan; 66(1):8-19. PubMed ID: 30509082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel miRNAs as potential biomarkers in stage II colon cancer: microarray analysis.
    Gungormez C; Gumushan Aktas H; Dilsiz N; Borazan E
    Mol Biol Rep; 2019 Aug; 46(4):4175-4183. PubMed ID: 31123908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EBV-transformed lymphoblastoid cell lines as vaccines against cancer testis antigen-positive tumors.
    Neumann F; Kaddu-Mulindwa D; Widmann T; Preuss KD; Held G; Zwick C; Roemer K; Pfreundschuh M; Kubuschok B
    Cancer Immunol Immunother; 2013 Jul; 62(7):1211-22. PubMed ID: 23619976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression levels of miR-143-3p and -424-5p in colorectal cancer and their clinical significance.
    Sahami-Fard MH; Kheirandish S; Sheikhha MH
    Cancer Biomark; 2019; 24(3):291-297. PubMed ID: 30883340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic silencing of the intronic microRNA hsa-miR-342 and its host gene EVL in colorectal cancer.
    Grady WM; Parkin RK; Mitchell PS; Lee JH; Kim YH; Tsuchiya KD; Washington MK; Paraskeva C; Willson JK; Kaz AM; Kroh EM; Allen A; Fritz BR; Markowitz SD; Tewari M
    Oncogene; 2008 Jun; 27(27):3880-8. PubMed ID: 18264139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RWR-algorithm-based dissection of microRNA-506-3p and microRNA-140-5p as radiosensitive biomarkers in colorectal cancer.
    Liao F; Chen X; Peng P; Dong W
    Aging (Albany NY); 2020 Oct; 12(20):20512-20522. PubMed ID: 33033230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer.
    Hu JL; Wang W; Lan XL; Zeng ZC; Liang YS; Yan YR; Song FY; Wang FF; Zhu XH; Liao WJ; Liao WT; Ding YQ; Liang L
    Mol Cancer; 2019 May; 18(1):91. PubMed ID: 31064356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.